Echocardiographic Findings in Patients With COVID-19 Pneumonia
Echocardiographic Findings in Patients With COVID-19 Pneumonia
复制标题
DOI：
10.1016/j.cjca.2020.05.030
复制
发表时间：
2020-08-01
影响因子：
6.2
通讯作者：
Steeds, Richard P.
中科院分区：
文献类型：
--
作者：
Mahmoud-Elsayed, Hani M.;Moody, William E.;Steeds, Richard P.
本研究的目的是描述COVID-19肺炎患者的超声心动图表型及其与生物标志物的关系。74名因COVID-19入院的患者（59 +/- 13岁，78%为男性）在转诊后接受经胸超声心动图检查作为常规护理的一部分。使用英国超声心动图学会1级经胸超声心动图评估心室大小和功能、瓣膜疾病以及肺动脉高压的可能性。主要异常为右心室（RV）扩张（41%）和右心室功能障碍（27%）。右心室损害与D-二聚体和C-反应蛋白水平升高相关。相反，大多数（89%）患者的左心室功能为高动力或正常。
The aim of this study was to characterize the echocardiographic phenotype of patients with COVID-19 pneumonia and its relation to biomarkers. Seventy-four patients (59 +/- 13 years old, 78% male) admitted with COVID-19 were included after referral for transthoracic echocardiography as part of routine care. A level 1 British Society of Echocardiography transthoracic echocardiography was used to assess chamber size and function, valvular disease, and likelihood of pul-monary hypertension. The chief abnormalities were right ventricle (RV) dilatation (41%) and RV dysfunction (27%). RV impairment was associated with increased D-dimer and C-reactive protein levels. In contrast, left ventricular function was hyperdynamic or normal in most (89%) patients.